Matches in SemOpenAlex for { <https://semopenalex.org/work/W3032291098> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W3032291098 endingPage "749" @default.
- W3032291098 startingPage "747" @default.
- W3032291098 abstract "Objective To compare the effect and toxicity of domestic idarubicin (IDA) and imported daunorubicin (DNR) in the treatment of acute leukemia (AL).Methods According to the random number table method,68 patients were randomly divided in IDA group with 35 patients and DNR group with 33 patients.In IDA group,the patients with acute myelocytic leukemia were treated following IA scheme (domestic idataubicin plus cytosine arabinoside) and the patients with acute lymphoblastic leukemia were treated following VICLP scheme (vincristine,domestic idataubicin,cyclophosphamide,lasparaginase and prednisone).In DNR group,the patients with acute myelocytic leukemia were treated following DA scheme (imported daunorubicin plus cytosine arabinoside) and the patients with acute lymphoblastic leukemia were treated following VDCLP scheme (vincristine,imported daunorubicin,cyclophosphamide,lasparaginase and prednisone).Results In IDA group,21 patients achieved a complete remission(CR),5 patients achieved a partial remission(PR),with a 74.2 ％ (26/35) remission rate (RR).In DNR group,the remission rate was 62.3 ％ (20/33).No differences of the remission rate was found between the two groups (t =0.89,P =0.50).17 patients were found remission over one year in IDA group,and 6 patients were in DNR group.The difference was statistically significant between the two groups (x2 =5.56,P =0.02).Conclusion IDA is more effective than DNR in AL treatment.The higher RR and longer remission time are found in IDA group than DNR group.IDA is effective and safe in the treatment of AL.Key words: Leukemia; Daunorubicin; Demethoxydaunor; Treatment outcome" @default.
- W3032291098 created "2020-06-05" @default.
- W3032291098 creator A5008315702 @default.
- W3032291098 creator A5068297054 @default.
- W3032291098 creator A5068437924 @default.
- W3032291098 creator A5075059545 @default.
- W3032291098 creator A5084482443 @default.
- W3032291098 date "2011-12-25" @default.
- W3032291098 modified "2023-09-22" @default.
- W3032291098 title "Comparison of domestic idataubicin and imported daunorubicin on the treatment of acute leukemia" @default.
- W3032291098 doi "https://doi.org/10.3760/cma.j.issn.1009-9921.2011.12.013" @default.
- W3032291098 hasPublicationYear "2011" @default.
- W3032291098 type Work @default.
- W3032291098 sameAs 3032291098 @default.
- W3032291098 citedByCount "1" @default.
- W3032291098 countsByYear W30322910982016 @default.
- W3032291098 crossrefType "journal-article" @default.
- W3032291098 hasAuthorship W3032291098A5008315702 @default.
- W3032291098 hasAuthorship W3032291098A5068297054 @default.
- W3032291098 hasAuthorship W3032291098A5068437924 @default.
- W3032291098 hasAuthorship W3032291098A5075059545 @default.
- W3032291098 hasAuthorship W3032291098A5084482443 @default.
- W3032291098 hasConcept C126322002 @default.
- W3032291098 hasConcept C141071460 @default.
- W3032291098 hasConcept C2776694085 @default.
- W3032291098 hasConcept C2776755627 @default.
- W3032291098 hasConcept C2776863199 @default.
- W3032291098 hasConcept C2778041864 @default.
- W3032291098 hasConcept C2778461978 @default.
- W3032291098 hasConcept C2778720950 @default.
- W3032291098 hasConcept C2779117419 @default.
- W3032291098 hasConcept C2779429289 @default.
- W3032291098 hasConcept C2781021840 @default.
- W3032291098 hasConcept C71924100 @default.
- W3032291098 hasConcept C90924648 @default.
- W3032291098 hasConceptScore W3032291098C126322002 @default.
- W3032291098 hasConceptScore W3032291098C141071460 @default.
- W3032291098 hasConceptScore W3032291098C2776694085 @default.
- W3032291098 hasConceptScore W3032291098C2776755627 @default.
- W3032291098 hasConceptScore W3032291098C2776863199 @default.
- W3032291098 hasConceptScore W3032291098C2778041864 @default.
- W3032291098 hasConceptScore W3032291098C2778461978 @default.
- W3032291098 hasConceptScore W3032291098C2778720950 @default.
- W3032291098 hasConceptScore W3032291098C2779117419 @default.
- W3032291098 hasConceptScore W3032291098C2779429289 @default.
- W3032291098 hasConceptScore W3032291098C2781021840 @default.
- W3032291098 hasConceptScore W3032291098C71924100 @default.
- W3032291098 hasConceptScore W3032291098C90924648 @default.
- W3032291098 hasIssue "12" @default.
- W3032291098 hasLocation W30322910981 @default.
- W3032291098 hasOpenAccess W3032291098 @default.
- W3032291098 hasPrimaryLocation W30322910981 @default.
- W3032291098 hasRelatedWork W129669046 @default.
- W3032291098 hasRelatedWork W2019793347 @default.
- W3032291098 hasRelatedWork W2083297370 @default.
- W3032291098 hasRelatedWork W2191003384 @default.
- W3032291098 hasRelatedWork W2255559795 @default.
- W3032291098 hasRelatedWork W2349483388 @default.
- W3032291098 hasRelatedWork W2363347453 @default.
- W3032291098 hasRelatedWork W2367296648 @default.
- W3032291098 hasRelatedWork W2375746266 @default.
- W3032291098 hasRelatedWork W2377863656 @default.
- W3032291098 hasRelatedWork W2398728262 @default.
- W3032291098 hasRelatedWork W2400677031 @default.
- W3032291098 hasRelatedWork W2413479554 @default.
- W3032291098 hasRelatedWork W2418628712 @default.
- W3032291098 hasRelatedWork W2470434425 @default.
- W3032291098 hasRelatedWork W2557880839 @default.
- W3032291098 hasRelatedWork W2979459974 @default.
- W3032291098 hasRelatedWork W3029234495 @default.
- W3032291098 hasRelatedWork W614014027 @default.
- W3032291098 hasRelatedWork W63719476 @default.
- W3032291098 hasVolume "20" @default.
- W3032291098 isParatext "false" @default.
- W3032291098 isRetracted "false" @default.
- W3032291098 magId "3032291098" @default.
- W3032291098 workType "article" @default.